compared to a few decades back when mantle cell lymphoma was really seen as a poor prognosis disease, we're seeing patients do a lot better. But obviously the next frontier, as it were ...

And I would say, that for a number of reasons, one is, the clinical context in which patients present ... to anticipate that they are mantle cell lymphoma, but quite frankly, most pathologists ...

Patients who experience NHS admin issues - such as chasing test results or not being updated on waiting times - are less likely to seek care in the future, new research has found. It comes as a ...

Intravascular large B-cell lymphoma (IVLBCL) is a rare type of non-Hodgkin’s lymphoma. Its symptoms can vary, making it difficult to diagnose. The outlook for people with IVLBCL is typically poor.

Patients who encounter administrative problems in the NHS, such as having to chase test results or not being updated about waiting times for treatment, are less likely to seek care in the future, ...

This systematic review evaluated 15 studies involving 1,307 patients to assess the diagnostic performance of these imaging modalities. Richter’s transformation, a shift from CLL to an aggressive large ...

2025 – The FDA has approved a new pill to treat adults with a type of blood cancer called mantle cell lymphoma (MCL ... in the United States. While patients usually respond to early treatment ...

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...

Add articles to your saved list and come back to them any time. The state government has set aside $100 million to divert patients waiting for elective surgery in a public hospital through the ...

Outpatient lymphodepletion followed by Tecartus was found to be safe and effective in treating B-cell acute lymphoblastic leukemia and mantle cell lymphoma.

Found early, cutaneous T-cell lymphoma is generally not deadly. With proper treatment, many people live long lives and living with this cancer is more like having a chronic disease that you need to ...